202 related articles for article (PubMed ID: 29933751)
41. α-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression.
Ikeda H; Sato Y; Yoneda N; Harada K; Sasaki M; Kitamura S; Sudo Y; Ooi A; Nakanuma Y
Hum Pathol; 2012 Nov; 43(11):1955-63. PubMed ID: 22516245
[TBL] [Abstract][Full Text] [Related]
42. A case of alpha-fetoprotein-producing adenocarcinoma of the endometrium with a hepatoid component as a potential source for alpha-fetoprotein in a postmenopausal woman.
Takeuchi K; Kitazawa S; Hamanishi S; Inagaki M; Murata K
Int J Gynecol Cancer; 2006; 16(3):1442-5. PubMed ID: 16803544
[TBL] [Abstract][Full Text] [Related]
43. Malignant ovarian tumor composed of endometrioid adenocarcinoma, clear cell adenocarcinoma, squamous cell carcinoma, yolk sac tumor and immature teratoma with prominent neuroectodermal and rhabdomyosarcomatous differentiation: a case study.
Ohishi Y; Kaku T; Kaneki E; Wake N; Tsuneyoshi M
Gynecol Oncol; 2007 May; 105(2):548-52. PubMed ID: 17341430
[TBL] [Abstract][Full Text] [Related]
44. Alpha-fetoprotein producing uterine corpus carcinoma: A hepatoid adenocarcinoma of the endometrium.
Toyoda H; Hirai T; Ishii E
Pathol Int; 2000 Oct; 50(10):847-52. PubMed ID: 11107058
[TBL] [Abstract][Full Text] [Related]
45. Hepatocyte paraffin 1 antibody does not distinguish primary ovarian tumors with hepatoid differentiation from metastatic hepatocellular carcinoma.
Pitman MB; Triratanachat S; Young RH; Oliva E
Int J Gynecol Pathol; 2004 Jan; 23(1):58-64. PubMed ID: 14668552
[TBL] [Abstract][Full Text] [Related]
46. alpha-Fetoprotein-producing liver carcinomas of primary extrahepatic origin.
Wee A; Thamboo TP; Thomas A
Acta Cytol; 2003; 47(5):799-808. PubMed ID: 14526683
[TBL] [Abstract][Full Text] [Related]
47. [Molecular heterogeneity of alpha-fetoprotein in ovarian or extragonadal yolk sac tumor].
Ishiguro T; Yoshida Y
Nihon Sanka Fujinka Gakkai Zasshi; 1991 Apr; 43(4):391-8. PubMed ID: 1712373
[TBL] [Abstract][Full Text] [Related]
48. Growth-suppressing function of glypican-3 (GPC3) via insulin like growth factor II (IGF-II) signaling pathway in ovarian clear cell carcinoma cells.
Sakurai M; Shibata K; Umezu T; Kajiyama H; Yamamoto E; Ino K; Nawa A; Kikkawa F
Gynecol Oncol; 2010 Nov; 119(2):332-6. PubMed ID: 20701957
[TBL] [Abstract][Full Text] [Related]
49. Alpha-fetoprotein localization in pure ovarian teratoma. An immunohistochemical study of 12 cases.
Perrone T; Steeper TA; Dehner LP
Am J Clin Pathol; 1987 Dec; 88(6):713-7. PubMed ID: 2446493
[TBL] [Abstract][Full Text] [Related]
50. Morphologic, immunohistochemical, and fluorescence in situ hybridization study of ovarian embryonal carcinoma with comparison to solid variant of yolk sac tumor and immature teratoma.
Cheng L; Zhang S; Talerman A; Roth LM
Hum Pathol; 2010 May; 41(5):716-23. PubMed ID: 20096442
[TBL] [Abstract][Full Text] [Related]
51. Alpha-fetoprotein-producing rectal cancer: calculated tumor marker doubling time.
Sato Y; Sekine T; Ohwada S
J Surg Oncol; 1994 Apr; 55(4):265-8. PubMed ID: 7512675
[TBL] [Abstract][Full Text] [Related]
52. Recurrent immature teratoma: lack of correlation between serum level and immunohistochemical detection of serum alpha-fetoprotein.
Busmanis I; Tay SK
Pathology; 1998 Feb; 30(1):77-9. PubMed ID: 9534214
[TBL] [Abstract][Full Text] [Related]
53. Differentiation of ovarian serous carcinoma from ovarian clear cell carcinoma using a 10-gene signature selected by comprehensive gene expression analysis.
Nomura S; Watanabe T; Honma R; Matsukura S; Ito E; Imai JI; Kiko Y; Suzuki O; Hashimoto Y; Kojima M; Furukawa S; Soeda S; Watanabe S; Fujimori K
Fukushima J Med Sci; 2024 Apr; 70(2):65-73. PubMed ID: 38494731
[TBL] [Abstract][Full Text] [Related]
54. Alpha-fetoprotein-lectin binding as a marker of tumour activity or liver damage.
Marrink J; Sleijfer DT; de Vries EG; Schraffordt Koops H
Eur J Cancer; 1990; 26(9):969-72. PubMed ID: 1703772
[TBL] [Abstract][Full Text] [Related]
55. [General concepts of alpha-fetoprotein (AFP)-secreting tumors, with special reference to the histogenesis].
Okamoto T
Gan No Rinsho; 1987 Oct; 33(12):1397-401. PubMed ID: 2446022
[TBL] [Abstract][Full Text] [Related]
56. Transformation of an AFP-positive yolk sac carcinoma into an AFP-negative neoplasm. Evidence for in vivo cloning of the human parietal yolk sac carcinoma.
Damjanov I; Amenta PS; Zarghami F
Cancer; 1984 May; 53(9):1902-7. PubMed ID: 6200199
[TBL] [Abstract][Full Text] [Related]
57. A study on the microheterogeneity of alpha-fetoproteins produced by yolk sac and germ cell tumors.
Yamamoto R; Ohkouchi T; Wakui Y; Minobe S; Watari H; Shimizu K; Satomura S; Sakuragi N
Acta Obstet Gynecol Scand; 2003 Sep; 82(9):876-82. PubMed ID: 12911452
[TBL] [Abstract][Full Text] [Related]
58. Alpha-fetoprotein level in fetuses, infants, and children with ovarian masses: a literature review.
Matonóg A; Drosdzol-Cop A
Front Endocrinol (Lausanne); 2024; 15():1307619. PubMed ID: 38379864
[TBL] [Abstract][Full Text] [Related]
59. alpha-Fetoprotein-producing rectal carcinoma--a case report.
Taguchi J; Yano H; Sueda J; Yamaguchi R; Kojiro M; Shirouzu G; Hashimoto K
Kurume Med J; 1997; 44(4):339-48. PubMed ID: 9476478
[TBL] [Abstract][Full Text] [Related]
60. Renal cell carcinoma producing alpha-fetoprotein (AFP) with a unique lectins-affinity profile.
Minamoto T; Kitagawa M; Amano N; Tsukada Y; Hirose T; Mai M
J Surg Oncol; 1994 Apr; 55(4):215-21. PubMed ID: 7512672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
